Stock Analysis
Equifax Inc. (EFX) Stock Analysis
Equifax Inc. (EFX) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Equifax Inc. (EFX) currently has an AIQ Score of 57/100, indicating a neutral setup. Momentum is the strongest factor at 87/100. Risk is the weakest current factor at 36/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
EFX at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $175.57 |
| AIQ Score | 57/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Strong Buy |
| Market Cap | $21.88B |
| P/E Ratio (TTM) | 32.5 |
| Forward P/E | — |
| EPS (quarter ended 2026-06-30) | $1.55 |
| Revenue (quarter ended 2026-06-30) | $1.7B |
| Dividend Yield (TTM) | 1.17% |
| Beta | 1.3 |
| Volume | 2.54M |
| 52-week range | $137.01-$236.49 |
| RSI 14 | 79.3 |
| 50-Day SMA | $166.89 |
| 200-Day SMA | $178.27 |
| Analyst Price Target | $200.35 |
| Next Earnings | Feb 3, 2027 |
EFXEquifax Inc.
Industrials / Consulting Services
Low Priority
Above Peers
Latest quote
- Momentum87
- Value53
- Quality46
- Risk resilience36
- Sentiment—
EFX Stock Analysis Summary
Equifax Inc. (EFX) currently has an AIQ Score of 57/100, indicating a neutral setup. Momentum is the strongest factor at 87/100. Risk resilience is the weakest current factor at 36/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, EFX has AIQ Score of 57/100 with Momentum base of 87/100 and fading Risk resilience at 36/100. Wait for component alignment before adding exposure.
Momentum (87/100) leads while Risk resilience (36/100) lags. This cross-factor spread creates entry timing uncertainty.
Industrials · -0.55% stock move · EFX classified in Consulting Services.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is EFX Bullish or Bearish Right Now?
EFX currently has a neutral overall setup. Momentum is the strongest factor at 87/100, while Risk Resilience is weakest at 36/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Momentum is constructive at 87/100.
- - Price is +5.20% above its 50-day SMA.
- - Analyst target implies +14.11% upside from the latest quote.
- - Technical consensus has more buy votes than sell votes (35 vs 9).
- - Risk Resilience is weak at 36/100.
- - Price is -1.52% below its 200-day SMA.
Current Consensus
EFX's Technical Analysis Consensus is currently Strong Buy, with 35 buy, 1 neutral, and 9 sell votes. EFX's 14-day RSI is 79.3, which places the stock in an overbought momentum range. EFX's beta is 1.3, indicating greater market sensitivity than the broad market.
What Changed in EFX?
The largest recent change in EFX is Momentum moving up by 37.0 points over the available 7-day comparison window. Momentum remains the strongest visible factor.
What Would Change the EFX Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
EFX Decision Framework
Public evidence layers, setup checks, and risk context for Equifax Inc..
Equifax Inc. (EFX) Stock Analysis
Equifax Inc. has an AIQ Score of 57/100 in a Neutral regime. Momentum is strongest at 87/100. Beta is 1.34, above market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | EFX is in a Neutral AIQ regime with score 57/100. |
| Signal Conflict | The primary conflict is that momentum leads at 87/100 while risk lags at 36/100. |
| Factor Evidence | Momentum 87/100 · Value 53/100 · Quality 46/100 · Risk 36/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Momentum is the strongest factor at 87/100.
Momentum is 87/100 and RSI (14) is 79.3.
EFX is in a Neutral regime at 57/100.
Risk factor is 36/100 with beta 1.34 and annual volatility 40.68%.
Current conflict: momentum leads at 87/100 while risk lags at 36/100.
EFX Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
EFX Fundamentals
EFX valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
EFX Technical Analysis
EFX technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
EFX Stock Catalysts
Track EFX earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
EFX Dividend Analysis
EFX dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
EFX Financial Data
EFX revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
EFX Risk Analysis
EFX volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
EFX Stock News
EFX stock news, market tone, recent headlines, and catalyst context.
EFX vs Life Sciences / Tools / CRO Peers
Current peer cohort: EFX · EXAS · ILMN · LNTH · MEDP. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| EFX Current stock | 57/100 | 53/100 | 87/100 | 36/100 | -0.57 | 40.68% | Current |
| EXAS Exact Sciences | 46/100 | 37/100 | — | 67/100 | 2.89 | 43.79% | EFX vs EXAS |
| ILMN Illumina | 52/100 | 26/100 | 61/100 | 38/100 | 2.28 | 49.63% | EFX vs ILMN |
| LNTH Lantheus Holdings | 63/100 | 53/100 | 59/100 | 72/100 | 1.8 | 32.57% | EFX vs LNTH |
| MEDP Medpace Holdings | 63/100 | 30/100 | 88/100 | 55/100 | 0.59 | 44.57% | EFX vs MEDP |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Oct 21, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts3 recent quarterly periods are available for review.
Checked Oct 21, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching EFX
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for EFX
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
EFX Stock FAQ
What is EFX stock price today?
Equifax Inc.'s current stock price is $175.57. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is EFX bullish or bearish right now?
EFX's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is EFX's market cap?
EFX's market cap is $21.88B based on the latest completed market-close snapshot from Oct 21, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is EFX's current P/E ratio?
EFX's current P/E ratio is 32.5 based on the latest completed market-close snapshot from Oct 21, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is EFX's RSI?
EFX's 14-day RSI is 79.3 based on the latest completed market-close snapshot from Oct 21, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is EFX above its 50-day and 200-day moving averages?
EFX is 5.20% from its 50-day SMA and -1.52% from its 200-day SMA based on the latest completed market-close snapshot from Oct 21, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is EFX's next earnings date?
EFX's next earnings date is currently listed as Feb 3, 2027. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does EFX pay a dividend?
EFX's dividend yield is 1.17% based on the latest completed market-close snapshot from Oct 21, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.